Jeffrey A. Munsie Named Chief Legal Officer of Mineralys Therapeutics

Jeffrey A. Munsie was named Chief Legal Officer of Mineralys Therapeutics on March 24, 2026, according to GlobeNewswire.

NameJeffrey A. Munsie
RoleChief Legal Officer
CompanyMineralys Therapeutics
IndustryBiotechnology
LocationRadnor, PA
MoveAppointment
DateMarch 24, 2026
SourceGlobeNewswire

Mineralys Therapeutics appointed Jeffrey A. Munsie as Chief Legal Officer on March 24, 2026. He most recently served as Chief Legal Officer and Secretary at Orbital Therapeutics, and earlier held legal leadership roles at Concert Pharmaceuticals and Merrimack Pharmaceuticals. (Source: GlobeNewswire.)

Who is the Chief Legal Officer of Mineralys Therapeutics?

Jeffrey A. Munsie took the Chief Legal Officer role at Mineralys Therapeutics in March 2026, as reported by GlobeNewswire. Legal leadership changes often, so check Mineralys Therapeutics’s own leadership page for the latest. If you know of a newer move, tell us and we will update the directory.

Other general counsel moves in March 2026

Browse every appointment in the General Counsel Directory.

Source: GlobeNewswire. InhouseBlog summarizes publicly reported general counsel moves and links to the original report.

Does this information need updating? Email us at info@inhouseblog.com.